Concepedia

Husam Alwan

HA

4

Publications

483

Citations

4

H-Index

2003

Active since

Affiliations

AstraZeneca (United Kingdom)(Current)

Radboud University Nijmegen

Husam Alwan is an author at AstraZeneca (United Kingdom) specializing in medicine, pharmacology, and tumor microenvironment.

Top concepts

Publications per year

2003–2016

4

Publications

4

Ligand-induced Lysosomal Epidermal Growth Factor Receptor (EGFR) Degradation Is Preceded by Proteasome-dependent EGFR De-ubiquitination

Husam Alwan, E.J.J. van Zoelen, Jeroen E.M. van Leeuwen · Journal of Biological Chemistry · 2003 · 176 citations · Full text

, , +19

UBPY-mediated Epidermal Growth Factor Receptor (EGFR) De-ubiquitination Promotes EGFR Degradation

Husam Alwan, Jeroen E.M. van Leeuwen · Journal of Biological Chemistry · 2006 · 152 citations · Full text

Potent and Selective Inhibitors of MTH1 Probe Its Role in Cancer Cell Survival

Jason G. Kettle, Husam Alwan, Michał Biśta et al. · Journal of Medicinal Chemistry · 2016 · 135 citations · Full text

, , +18

A Generic Platform for Cellular Screening Against Ubiquitin Ligases

Timurs Maculins, Nikki Carter, Thierry Dorval et al. · Scientific Reports · 2016 · 20 citations · Full text

Rows per page

1–4 of 4